Prostate Cancer 2024: Diagnosis and Management in a New Era

Sunday, April 7, 2024

9:00am – 10:30am

Location:406

Prostate cancer diagnosis and management have been transformed by unprecedented developments in genomic testing, molecular profiling, and enhanced imaging technology. Ultrasound, MRI, and fusion technologies have improved evaluation and biopsy accuracy that allow therapeutic algorithms to improve individual outcomes and minimize the adverse impact of delayed diagnosis of clinically significant prostate cancers. Treatment with high-frequency ultrasound (HIFU) for certain cancers and specific clinical scenarios, as a result of the aforementioned diagnostic armamentarium, is changing the algorithm for more and more patients.

Moderator(s)

RM

Robert Mevorach, MD, FSPU, FAIUM

Chair, Urology Community AIUM, Associate Professor, University of South Alabama
University of South Alabama
Gulf Breeze, United States

Session Speaker(s)

SM

Sandeep Mistry, MD, MPH, MBS

North Austin Urology Specialist.s
Jatinder Kumar, MD (he/him/his)

Assistant Professor, Department of Urology, University of South Alabama
University of South Alabama
Mobile, United States

Learning Objectives:

Understand current rationale for prostate biopsy.
Discuss the defining criteria for clinically relevant prostate cancer.
Advise patients on the current role of targeted HIFU therapy in the care of prostate cancer.

Presentations:

9:05am – 9:35am

Prostate Cancer Diagnosis: Fusion Biopsy, Genomics, and Improved Outcomes
Jatinder Kumar, MD (he/him/his) – University of South Alabama
9:35am – 10:05am

HIFU and Prostate Cancer 2024
Sandeep G. Mistry, MD, MPH, MBS